Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients.

Venkat VL, Ranganathan S, Mazariegos GV, Sun Q, Sindhi R.

Liver Transpl. 2014 Jun;20(6):679-86. doi: 10.1002/lt.23868.

2.

A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.

Alabraba E, Nightingale P, Gunson B, Hubscher S, Olliff S, Mirza D, Neuberger J.

Liver Transpl. 2009 Mar;15(3):330-40. doi: 10.1002/lt.21679.

3.
4.

Risk factors for recurrent primary sclerosing cholangitis after liver transplantation.

Ravikumar R, Tsochatzis E, Jose S, Allison M, Athale A, Creamer F, Gunson B, Iyer V, Madanur M, Manas D, Monaco A, Mirza D, Owen N, Roberts K, Sen G, Srinivasan P, Wigmore S, Fusai G, Fernando B, Burroughs A.

J Hepatol. 2015 Nov;63(5):1139-46. doi: 10.1016/j.jhep.2015.07.005.

PMID:
26186988
5.

Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors.

Brandsaeter B, Schrumpf E, Bentdal O, Brabrand K, Smith HJ, Abildgaard A, Clausen OP, Bjoro K.

Liver Transpl. 2005 Nov;11(11):1361-9.

6.

Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.

Goss JA, Shackleton CR, Farmer DG, Arnaout WS, Seu P, Markowitz JS, Martin P, Stribling RJ, Goldstein LI, Busuttil RW.

Ann Surg. 1997 May;225(5):472-81; discussion 481-3.

7.

Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.

Cholongitas E, Shusang V, Papatheodoridis GV, Marelli L, Manousou P, Rolando N, Patch D, Rolles K, Davidson B, Burroughs AK.

Liver Transpl. 2008 Feb;14(2):138-43. doi: 10.1002/lt.21260.

8.

Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.

Kugelmas M, Spiegelman P, Osgood MJ, Young DA, Trotter JF, Steinberg T, Wachs ME, Bak T, Kam I, Everson GT.

Liver Transpl. 2003 Jul;9(7):727-32.

9.

Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.

Alexander J, Lord JD, Yeh MM, Cuevas C, Bakthavatsalam R, Kowdley KV.

Liver Transpl. 2008 Feb;14(2):245-51. doi: 10.1002/lt.21394.

10.

Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.

Cao S, Cox KL, Berquist W, Hayashi M, Concepcion W, Hammes GB, Ojogho OK, So SK, Frerker M, Castillo RO, Monge H, Esquivel CO.

Pediatr Transplant. 1999 Feb;3(1):22-6.

PMID:
10359027
11.

Pediatric liver transplantation for primary sclerosing cholangitis.

Miloh T, Anand R, Yin W, Vos M, Kerkar N, Alonso E; Studies of Pediatric Liver Transplantation Research Group..

Liver Transpl. 2011 Aug;17(8):925-33. doi: 10.1002/lt.22320.

12.

Recurrence of primary sclerosing cholangitis after liver transplantation - The Hungarian experience.

Gelley F, Zádori G, Görög D, Kóbori L, Fehérvári I, Gámán G, Gerlei Z, Nagy P, Sárváry E, Nemes B.

Interv Med Appl Sci. 2014 Mar;6(1):16-8. doi: 10.1556/IMAS.6.2014.1.2.

13.

Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.

Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, Charlton MR, Poterucha JJ, Rosen CB, Gores GJ, LaRusso NF, Krom RA.

Hepatology. 1999 Nov;30(5):1121-7.

PMID:
10534330
14.

Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course.

Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, Kam I.

Liver Transpl. 2008 Feb;14(2):181-5. doi: 10.1002/lt.21313.

15.

HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation.

Fosby B, Næss S, Hov JR, Traherne J, Boberg KM, Trowsdale J, Foss A, Line PD, Franke A, Melum E, Scott H, Karlsen TH.

World J Gastroenterol. 2014 Apr 14;20(14):3986-4000. doi: 10.3748/wjg.v20.i14.3986.

16.

Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.

Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, Mayer A, Buckels JA, McMaster P, Neuberger J, Mirza DF.

Transplantation. 2003 Jun 27;75(12):1983-8.

PMID:
12829898
17.

Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis.

Hildebrand T, Pannicke N, Dechene A, Gotthardt DN, Kirchner G, Reiter FP, Sterneck M, Herzer K, Lenzen H, Rupp C, Barg-Hock H, de Leuw P, Teufel A, Zimmer V, Lammert F, Sarrazin C, Spengler U, Rust C, Manns MP, Strassburg CP, Schramm C, Weismüller TJ; German PSC Study Group..

Liver Transpl. 2016 Jan;22(1):42-52. doi: 10.1002/lt.24350.

18.

Childhood autoimmune liver disease: indications and outcome of liver transplantation.

Chai PF, Lee WS, Brown RM, McPartland JL, Foster K, McKiernan PJ, Kelly DA.

J Pediatr Gastroenterol Nutr. 2010 Mar;50(3):295-302. doi: 10.1097/MPG.0b013e3181bf0ef7.

PMID:
20118802
19.

The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.

Jain A, Mazariegos G, Pokharna R, Parizhskaya M, Kashyap R, Kosmach-Park B, Smith A, Fung JJ, Reyes J.

Transplantation. 2003 Apr 15;75(7):1020-5.

PMID:
12698091
20.

Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?

Jeyarajah DR, Netto GJ, Lee SP, Testa G, Abbasoglu O, Husberg BS, Levy MF, Goldstein RM, Gonwa TA, Tillery GW, Crippin JS, Klintmalm GB.

Transplantation. 1998 Nov 27;66(10):1300-6.

PMID:
9846512
Items per page

Supplemental Content

Support Center